CD34 and myeloid sarcoma: In details, analysis highlighted that in MS group compared with healthy control group, mean CD34+ cells are increased by 47,9% (p = 0.030), 96.1% (p = 0.010), and 63.7% (p = 0.027) during the first trimester, the third trimester and at delivery, respectively (fig.